News

Drugmaker Eli Lilly plans to buy Verve Therapeutics, a gene-editing startup, for about $1 billion upfront. The deal gives ...
U.S. regulators will begin offering faster reviews to new medicines that administration officials deem as promoting “the ...
The agency declined to quickly release documents that would identify drugs made at some of the most troubled foreign ...
FDA Commissioner Marty Makary faces declining staff morale as he remakes the agency.
Kraft Heinz announced on Tuesday that it would be removing artificial food dyes from its products within the next two years.
The FDA is launching a program to reward companies with accelerated drug review and speedy agency feedback, if their actions ...
U.S. health officials said that they would urge foodmakers to phase out petroleum-based artificial colors in the nation’s ...
The US Food and Drug Administration announced a new national priority voucher plan that aims to cut drug review times to one ...
HHS secretary Robert F. Kennedy Jr. declared that the FDA’s “suppression of psychedelics” was about to end. Now he and his ...
Leaders of the FDA have published a list of new priorities for the agency. They want to deliver rapidly-approved cures and ...
A new study from the American Cancer Society’s medical journal found that psilocybin — the active ingredient in “magic ...